Current aspects of adjuvant therapy of early stage ovarian cancer
McGuire, W.P.
Zentralblatt für Gynakologie 120(3): 93-97
1998
ISSN/ISBN: 0044-4197 PMID: 9556898 Document Number: 488737
Early ovarian cancer, stages I and II, is a rare presentation of epithelial ovarian cancer for which adjuvant therapy may have some efficacy. More than two decades of studies are reviewed and conclusions offered. Additionally, important issues for the future therapy of this disease are presented.
Document emailed within 1 workday
Related Documents
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229Lin, H.; ChangChien, C.C.; Chang, S.Y.; Leung, S.W. 1998: Survival advantages and complications of adjuvant therapy in early-stage cervical cancer with pelvic node metastasis Changgeng Yi Xue Za Zhi 21(4): 383-390
Scutariu, M.Mihaela.; Voroneanu, M. 2006: Current aspects of risk factors in early stage cancer of the oral cavity Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 425-431
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Sato, Y.; Yajima, K.; Kosugi, S-ichi.; Muneoka, Y.; Ichikawa, H.; Hanyu, T.; Sakamoto, K.; Ishikawa, T.; Wakai, T. 2014: Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(8): 961-964
Yamaguchi, M.; Fukuyama, Y.; Ichinose, Y. 2003: Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 203-208
Segev, Y.; Ismiil, N.; McVey, R.; Covens, A. 2015: Surgical Stage i high-grade ovarian cancer: is adjuvant chemotherapy warranted? European Journal of Gynaecological Oncology 36(6): 633-636
Perez, E.; Muss, H.B. 2005: Optimizing adjuvant chemotherapy in early-stage breast cancer Oncology 19(14): 1759-1767; Discussion 1768: 1772-1774; 1777-1778
Machin, D.; Andersen, K.W. 1997: Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer Journal of the National Cancer Institute 89(9): 659-660
Kadakia, K.C.; Worrilow, W.M.; Coley, H.; Salem, M.E. 2019: Optimal duration of adjuvant therapy for stage IIi colon cancer Clinical Advances in Hematology and Oncology: H&o 17(5): 289-298
Horová, H.; Růzicková, J.; Jezková, B.; Horová, I.; Budíková, M.; Dörr, A. 2004: Adjuvant radiotherapy in the therapy of uterine cancer in the first clinical stage Ceska Gynekologie 69(5): 366-371
2015: (S045) Equivalent Survival With Breast-Conserving Therapy and Mastectomy in Young Women Under the Age of 40 With Early-Stage Breast Cancer: A National Registry-Based Stage-by-Stage Comparison Oncology 29(4 Suppl. 1)
O'Connell, M.J. 2004: Current status of adjuvant therapy for colorectal cancer Oncology 18(6): 751
Movsas, B. 2001: Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer Oncology 15(12): 1549-1558
Marshall, J.S.; Gordon, N.H.; Hubay, C.A.; Pearson, O.H. 1987: Assessment of tamoxifen as adjuvant therapy in stage Ii breast cancer: a long-term follow-up Journal of Laboratory and Clinical Medicine 109(3): 300-307
Rose, D.P.; Davis, T.E. 1980: Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients Cancer Research 40(11): 4043-4047
Kato, A.; Miyazaki, M. 2014: Current status of adjuvant therapy for biliary tract cancer Nihon Geka Gakkai Zasshi 115(4): 206-211
Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
2015: (S029) evaluating the role of a 21-gene expression assay in directing adjuvant radiotherapy decisions for elderly women with early-stage breast cancer Oncology 29(4 Suppl. 1)
Lotze, W. 1991: Current aspects of diagnosis, therapy and follow-up care of ovarian carcinoma Zeitschrift für Arztliche Fortbildung 85(6): 242-245